How to turn evidence into policy in resource-limited settings - Nature Medicine

日本 ニュース ニュース

How to turn evidence into policy in resource-limited settings - Nature Medicine
日本 最新ニュース,日本 見出し
  • 📰 NatureMedicine
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 53%

How to turn evidence into policy in resource-limited settings. World View from Patti Gravitt, NCIGlobalHealth, as part of our series Rethinking Evidence in Medicine.

Beginning in the 1990s, evidence accumulated to show that infection with specific high-risk genotypes of human papillomavirus was a necessary but insufficient cause of invasive cervical cancer. Within a decade, this evidence was translated into HPV immunization and high-risk HPV-based screening.

A vast international effort ensured that these new HPV-based strategies could be implemented in resource-constrained as well as high-resource settings, so that global disparities could be reduced or eliminated. Unfortunately, these interventions have been slow to translate. HPV immunization and screening remain unacceptably low in countries with the highest burden.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

NatureMedicine /  🏆 451. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Personalized antisense oligonucleotides ‘for free, for life’ — the n-Lorem Foundation - Nature MedicinePersonalized antisense oligonucleotides ‘for free, for life’ — the n-Lorem Foundation - Nature MedicinePersonalized antisense oligonucleotides ‘for free, for life’ — the n-Lorem Foundation. Correspondence from jogleeson_ucsd DrStanleyCrooke and colleagues n_lorem
続きを読む »

Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man - Nature MedicineResilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man - Nature MedicineCase report of an individual heterozygous for a rare RELN-COLBOS variant that confers resilience, via a gain-of-function mechanism, to Alzheimer’s disease. ytquiroz DrJoeArboleda diegosflab
続きを読む »

Neoadjuvant immunotherapy for melanoma is now ready for clinical practice - Nature MedicineNeoadjuvant immunotherapy for melanoma is now ready for clinical practice - Nature MedicineIndividuals with cutaneous melanoma who are treated with neoadjuvant immunotherapy show a substantial improvement; this should be incorporated into standard care.
続きを読む »

Adolescent medicine doctors out at Dell Children's amid Paxton probe of gender-affirming careAdolescent medicine doctors out at Dell Children's amid Paxton probe of gender-affirming careAll doctors staffing Dell Children’s adolescent medicine clinic are departing after Texas Attorney General Ken Paxton announced an investigation into whether gender-affirming care procedures were “unlawfully performed on minor children” at the hospital.
続きを読む »

Expert Perspectives on the Potential Capabilities and Pitfalls for AI-Based Language Tools in MedicineExpert Perspectives on the Potential Capabilities and Pitfalls for AI-Based Language Tools in Medicine❓ Are you aware of the latest information regarding AI tools in medicine? Learn from experts on the pros and cons of AI in medicine. MedEd 📍 Click here to learn:
続きを読む »

‘Will I die if I don’t get my medicine’ – Congress examines drug shortages‘Will I die if I don’t get my medicine’ – Congress examines drug shortagesPeople can’t get the medications they need to survive or live healthier lives because of drug shortages.
続きを読む »



Render Time: 2025-03-04 18:22:11